Ajooni Biotech: Should You Buy, Hold, or Sell Right Now?

Ajooni Biotech share price is trading around Rs 3.7 on the NSE, close to its 52-week low of Rs 3.40, roughly 37 percent below its 52-week high of Rs 5.94. Given the very small scale of this company and limited recent quarterly data, this article presents what is known plainly before laying out a balanced view.

This Ajooni Biotech overview walks through the available valuation data, the significant data limitations, and the technical setup, using figures sourced from public filings, with appropriate caveats given the penny-stock nature of the shares.

Click Here – Get Free Investment Predictions

About Ajooni Biotech

Before deciding on Ajooni Biotech share price, it helps to understand the underlying business. Ajooni Biotech Ltd. operates in the poultry and agri-biotech space, with a market capitalisation of approximately Rs 64 crore, a scale where trading liquidity and financial disclosure depth can differ meaningfully from larger, more established companies.

Current-quarter financial data for the company was not consistently available across public sources at the time of writing, meaning investors should seek the company's latest exchange filings directly for more current information before making any decision.

Ajooni Biotech Share Price Today: Key Levels

The table below summarises where Ajooni Biotech share price stands right now against its recent trading range and market value.

Metric	Value
Ajooni Biotech CMP (NSE)	Rs 3.71
52-Week High	Rs 5.94
52-Week Low	Rs 3.40
Market Capitalisation	Approximately Rs 64 crore

Ajooni Biotech share price is trading close to its 52-week low, reflecting limited market attention typical of this very small, penny-stock-level company.

Check the Univest Screener for Live Stock Data

Ajooni Biotech Financial Performance

The Ajooni Biotech share price trend is closely tied to how these numbers evolve each quarter. Current-quarter financial data for Ajooni Biotech was not consistently available across public sources at the time of writing. The company's trailing twelve-month figures show a positive EPS of Rs 0.23 and a return on equity of 4.74 percent, indicating the business is currently generating a modest positive return.

Investors should refer directly to the company's latest exchange filings for updated quarterly figures before drawing conclusions about the current trend, given the limited publicly available recent data.

Period	Revenue	Net Profit	Comment
Trailing twelve months	Not fully disclosed publicly	EPS Rs 0.23 (modest profit)	Current-quarter data not consistently available

Valuation Check: Is Ajooni Biotech Share Price Expensive?

Any view on Ajooni Biotech share price should start from these valuation multiples. Ajooni Biotech share price currently reflects a price to earnings ratio of about 16.13 times trailing earnings, a discount to the broader agri-biotech sector average of roughly 37.6 times. The price to book ratio stands at 0.70 times, meaning the stock trades below its own reported book value.

Debt to equity of 0.19 is moderate. Given the very small scale and data limitations, standard valuation comparisons carry reduced reliability here, and investors should treat this discount with appropriate caution rather than assuming it represents clear value.

Technical Signals: What the Chart Shows

Price action here often foreshadows the next move in Ajooni Biotech share price. Ajooni Biotech share price is currently positioned close to its 52-week low of Rs 3.40, roughly 37 percent below its 52-week high of Rs 5.94. Given the penny-stock price level and thin trading typical of this stock, technical signals should be read with particular caution.

Investors should track Ajooni Biotech share price alongside any updated company disclosures, rather than relying on price action alone given the limited data currently available.

Download the Univest iOS App or Univest Android App to track Ajooni Biotech's live price and technical levels.

Shareholding Pattern

Shifts here can influence Ajooni Biotech share price more than headline news on some sessions. Ajooni Biotech is a small, promoter-led poultry and agri-biotech company. A detailed current promoter, FII and DII percentage breakdown was not consistently available across sources at the time of writing and should be verified on the company's latest exchange filing.

Why Investors Are Watching Ajooni Biotech

• Discount valuation to sector: A 16.13x PE against a 37.6x sector average, alongside a below-book valuation, offers some cushion for investors comfortable with the risk involved.
• Modest but positive trailing profitability: A positive trailing EPS and a return on equity of 4.74 percent indicate the business is currently generating a modest positive return.

Risks and Factors to Watch

• Very significant data limitations: Current-quarter financial data was not consistently available across public sources at the time of writing, creating a meaningful information gap for investors.
• Penny-stock price level: Trading at under Rs 4 per share, Ajooni Biotech carries the elevated volatility and liquidity risks typical of penny stocks.
• Very small scale and thin liquidity: As a small company with a market capitalisation of approximately Rs 64 crore, this stock carries elevated risks typical of very small, thinly-traded companies.
• Agri-biotech sector cyclicality: As a poultry and agri-biotech company, results can be exposed to input cost cycles and sector-specific demand fluctuations.

Ajooni Biotech Share Price Target: What the Data Suggests

Until then, Ajooni Biotech share price remains best tracked through live, verified data rather than a single fixed number. Ajooni Biotech does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time, given the limited current data available.

Investors considering this stock should seek the company's most recent exchange filings directly, and should consult a SEBI-registered investment adviser given the very small scale and penny-stock nature of the shares.

Ajooni Biotech: Should You Buy, Hold, or Sell Right Now?

This is the core question behind Ajooni Biotech share price right now. The Ajooni Biotech buy or sell decision should account for the very significant data limitations and penny-stock nature of the shares.

The case for buying: Only investors who have independently sourced more current company filings and are comfortable with penny-stock risk may consider a position.

The case for holding: Existing shareholders who already accept this risk profile may choose to continue holding.

The case for avoiding: Most investors, particularly those preferring companies with clear, current financial disclosure and less price volatility, would reasonably prefer to avoid this stock.

Given the data limitations here, consult a SEBI-registered investment adviser before proceeding.

Conclusion

Ajooni Biotech share price reflects a very small poultry and agri-biotech company trading at penny-stock levels with limited current financial disclosure, close to its 52-week low. This is a niche, thinly-traded stock requiring particular diligence. This article is for informational purposes and not a personalised investment recommendation.

Q1. Is Ajooni Biotech a good stock to buy right now?

Ans. Ajooni Biotech trades at a discount to its sector with modest positive trailing profitability, but current-quarter data was not consistently available at the time of writing. Given the penny-stock price level and small scale, this suits only investors who have independently sourced updated company filings.

Q2. What is the Ajooni Biotech share price today?

Ans. Ajooni Biotech share price is trading around Rs 3.7 on the NSE, close to its 52-week low of Rs 3.40. The stock's 52-week high is Rs 5.94.

Q3. What is the Ajooni Biotech share price target?

Ans. Ajooni Biotech does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time, given the limited current data available.

Q4. What does Ajooni Biotech do?

Ans. Ajooni Biotech operates in the poultry and agri-biotech space.

Q5. What is Ajooni Biotech's market capitalisation?

Ans. Ajooni Biotech has a market capitalisation of approximately Rs 64 crore, making it a very small, penny-stock-level company.

Q6. Is Ajooni Biotech profitable?

Ans. Ajooni Biotech's trailing twelve-month figures show a modest positive EPS of Rs 0.23 and a return on equity of 4.74 percent, though current-quarter details were not consistently disclosed publicly.